Precise role of H pylori in duodenal ulceration

World Journal of Gastroenterology

Volumn 12, Issue 40, 2006, Pages 6413-6419

  Hobsley, Michael ^a,b   Tovey, Frank I ^a   Holton, John ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

Delays healing; Duodenal ulceration; H pylori infection; Not causal

Indexed keywords

ANTIBIOTIC AGENT; GASTRIN; NONSTEROID ANTIINFLAMMATORY AGENT; STOMACH SECRETION INHIBITOR; VIRULENCE FACTOR;

BACTERIAL GROWTH; BACTERIAL VIRULENCE; CHRONICITY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DUODENUM ULCER; EDITORIAL; ERADICATION THERAPY; GEOGRAPHY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; INCIDENCE; INTESTINE SURGERY; OUTCOME ASSESSMENT; PATHOGENESIS; PREDICTION; PREVALENCE; RECURRENCE RISK; STOMACH ACID; STOMACH PH; ULCER HEALING; ULCER PERFORATION;

EID: 33751005853     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i40.6413     Document Type: Editorial

References (117)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315
2. Tovey FI, Hobsley M, Holton J. Helicobacter pylori virulence factors in duodenal ulceration: A primary cause or a secondary infection causing chronicity. World J Gastroenterol 2006; 12: 6-9
3. Segal I, Ally R, Sitas F, Walker AR. Co-screening for primary biliary cirrhosis and coeliac disease. Helicobacter pylori: the African enigma. Gut 1998; 43: 300-301
4. Boulos PB, Botha A, Hobsley M, Holton J, Oshowo AO, Tovey FI. Possible absence of Helicobacter pylori in the early stages of duodenal ulceration. QJM 2002; 95: 749-752
5. Pest P, Zarate J, Varsky C, Man F, Schraier M. Helicobacter pylori in recently-diagnosed versus chronic duodenal ulcer. Acta Gastroenterol Latinoam 1996; 26: 273-276
6. Bytzer P, Teglbjaerg PS. Helicobacter pylori-negative duodenal ulcers: prevalence, clinical characteristics, and prognosis--results from a randomized trial with 2-year follow-up. Am J Gastroenterol 2001; 96: 1409-1416
7. Gdalevich M, Cohen D, Ashkenazi I, Mimouni D, Shpilberg O, Kark JD. Helicobacter pylori infection and subsequent peptic duodenal disease among young adults. Int J Epidemiol 2000; 29: 592-595
8. Nomura A, Stemmermann GN, Chyou PH, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and the risk for duodenal and gastric ulceration. Ann Intern Med 1994; 120: 977-81
9. Schwarz K. Ueber penetrierende magen- und jejunal geshwure. Beitr Min Chir 1910; 67: 96-128
10. Hobsley M, Whitfield PF. The likelihood of a disease in relation to the magnitude of a risk factor. The example of duodenal ulcer. Theoretical Surgery 1987; 2: 6-9
11. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429-431
12. Holcombe C, Omatara BA, Eldridge J, Jones DM. Helicobacter pylori, the most common bacterial infection in Africa. A random serological study. Am J Gastroenterol 1992; 87: 28-30
13. Holcombe C, Omatara BA, Padonu MKO, Bassi AP. The prevalence of symptoms of dyspepsia in north eastern Nigeria: a random community based study. Trop Geog Med 1991; 43: 209-214
14. Segal I, Ally R, Mitchell H. Helicobacter pylori - an African perspective. QJM 2001; 94: 561-565
15. Tovey FI, Hobsley M, Segal I, Jayaraj AP. Duodenal ulcer in South Africa: home-pounded versus milled maize. J Gastroenterol Hepatol 2005; 20: 1008-1011
16. Tovey FI, Hobsley M, Kaushik SP, Pandey R, Kurian G, Singh K, Sood A, Jehangir E. Duodenal gastric metaplasia and Helicobacter pylori infection in high and low duodenal ulcer-prevalent areas in India. J Gastroenterol Hepatol 2004; 19: 497-505
17. Wong BC, Ching CK, Lam SK Li ZL, Chen BW, Li YN, Liu HJ, Liu JB, Wang BE, Yuan SZ, Xu CP, Hou XH, Zheng AT, Zheng ZT. Differential north to south gastric cancer-duodenal ulcer gradient in China. China Ulcer Study Group. J Gastroenterol Hepatol 1998; 13: 1050-1057
18. Ching CK, Lam SK. Helicobacter pylori epidemiology in relation to peptic ulcer and gastric cancer in south and north China. J Gastroenterol Hepatol 1994; 9 Suppl 1: S4-7
19. Jayaraj AP, Tovey FI, Clark CG. Possible dietary protective factors in relation to the distribution of duodenal ulcer in India and Bangladesh. Gut 1980; 21: 1068-1076
20. Jayaraj AP, Tovey FI, Lewin MR, Clark CG. Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids. J Gastroenterol Hepatol 2000; 15: 610-616
21. Tovey F. Peptic ulcer in India and Bangladesh. Gut 1979; 20: 329-347
22. Tovey FI, Tunstall M. Duodenal ulcer in black populations in Africa south of the Sahara. Gut 1975; 16: 564-576
23. Tovey FI. Duodenal ulcer in China. J Gastroenterol Hepatol 1992; 7: 427-431
24. Jayaraj AP, Tovey FI, Clark CG, Hobsley M. Dietary factors in relation to the distribution of duodenal ulcer in India as assessed by studies in rats. J Gastroenterol Hepatol 2001; 16: 501-505
25. Jayaraj AP, Tovey FI, Lewin MR, Clark CG. Duodenal ulcer prevalence: experimental evidence for the possible role of dietary lipids. J Gastroenterol Hepatol 2000; 15: 610-616
26. Jayaraj AP, Rees KR, Tovey FI, White JS. A molecular basis of peptic ulceration due to diet. Br J Exp Pathol 1986; 67: 149-155
27. Jayaraj AP, Tovey FI, Clark CG, Rees KR, White JS, Lewin MR. The ulcerogenic and protective action of rice and rice fractions in experimental peptic ulceration. Clin Sci (Lond) 1987; 72: 463-466
28. Paul Jayaraj A, Tovey FI, Hobsley M. Duodenal ulcer prevalence: research into the nature of possible protective dietary lipids. Phytother Res 2003; 17: 391-398
29. Jyotheeswaran S, Shah AN, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol 1998; 93: 574-578
30. Borody TJ, George LL, Brandl S, Andrews P, Ostapowicz N, Hyland L, Devine M. Helicobacter pylori-negative duodenal ulcer. Am J Gastroenterol 1991; 86: 1154-1157
31. Dwyer B, Sun NX, Kaldor J, Tee W, Lambert J, Luppino M, Flannery G. Antibody response to Campylobacter pylori in an ethnic group lacking peptic ulceration. Scand J Infect Dis 1988; 20: 63-68
32. Jones DM, Eldridge J, Fox AJ, Sethi P, Whorwell PJ. Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis") - clinical correlations and distribution in the normal population. J Med Microbiol 1986; 22: 57-62
33. Kang JY, Wee A, Math MV, Guan R, Tay HH, Yap I, Sutherland IH. Helicobacter pylori and gastritis in patients with peptic ulcer and non-ulcer dyspepsia: ethnic differences in Singapore. Gut 1990; 31: 850-853
34. Kochhar R, Siddeshi ER, Ayyagiri A, Bhasin DK, Metha SH. Campylobacter pylori in dyspeptic patients: a report from North India. Trans Roy Soc Trop Med Hygiene 1989; 83: 135
35. Lahaie RG, Lahaie M, Boivin M, Gagnon M, Lemoyne M, Nguyen B, Plourde V, Poitras S, Sahai A. Changing prevalence of Helicobacter pylori infection in endoscopically demonstrated duodenal ulcer. Gut 2000; 47 Suppl 1: A77-A78
36. Li YY, Hu PJ, Du GG, Hazell SL. The prevalence of Helicobacter pylori infection in the Peoples Republic of China. Am J Gastroenterol 1991; 86: 446-449
37. Azim Mirghani YA, Ahmed S, Ahmed M, Ismail MO, Fedail SS, Kamel M, Saidia H. Detection of Helicobacter pylori in endoscopic biopsies in Sudan. Trop Doct 1994; 24: 161-163
38. Saita H, Murakami M, Yoo JK, Teramura S, Dekigai H, Takahashi Y, Kita T. Link between Helicobacter pylori-associated gastritis and duodenal ulcer. Dig Dis Sci 1993; 38: 117-122
39. Uyub AM, Raj SM, Visvanathan R, Nazim M, Aiyar S, Anuar AK, Mansur M. Helicobacter pylori infection in north-eastern peninsular Malaysia. Evidence for an unusually low prevalence. Scand J Gastroenterol 1994; 29: 209-213
40. Meucci G, Di Battista R, Abbiati C, Benassi R, Bierti L, Bortoli A, Colombo E, Ferrara A, Prada A, Spinzi G, Venturelli R, de Franchis R. Prevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter study. J Clin Gastroenterol 2000; 31: 42-47
41. Prasad S, Mathan M, Chandy G, Rajan DP, Venkateswaran S, Ramakrishna BS, Mathan VI. Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease. J Gastroenterol Hepatol 1994; 9: 501-506
42. Al-Saadi AM, Al-Khayat JQ, Muhammad IM, Anwar SA. The role of Helicobacter pylori in esophagitis and peptic ulcer disease in Iraq. Saudi Med J 2004; 25: 1216-1222
43. Bakka AS, El-Gariani AB, AbouGhrara FM, Salih BA. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya. Saudi Med J 2002; 23: 1261-1265
44. Hu PJ, Li YY, Zhou MH, Chen MH, Du GG, Huang BJ, Mitchell HM, Hazell SL. Helicobacter pylori associated with a high prevalence of duodenal ulcer disease and a low prevalence of gastric cancer in a developing nation. Gut 1995; 36: 198-202
45. Kate V, Ananthakrishnan N, Badrinath S, Ratnakar C. Prevalence of Helicobacter pylori infection in disorders of the upper gastrointestinal tract in south India. Natl Med J India 1998; 11: 5-8
46. Kidd M, Louw JA, Marks IN. Helicobacter pylori in Africa: observations on an 'enigma within an enigma'. J Gastroenterol Hepatol 1999; 14: 851-858
47. Lachlan GW, Gilmour HM, Jass JJ. Campylobacter pylori in central Africa. Br Med J (Clin Res Ed) 1988; 296: 66
48. Lee HR, Han KS, Yoo BC, Park SM, Cha YJ. Prevalence of Helicobacter pylori infection in patients with peptic ulcer diseases and non-ulcer dyspepsia. Korean J Intern Med 1993; 8: 73-77
49. Nishikawa K, Sugiyama T, Kato M, Ishizuka J, Komatsu Y, Kagaya H, Katagiri M, Nishikawa S, Hokari K, Takeda H, Asaka M. Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population. Eur J Gastroenterol Hepatol 2000; 12: 635-640
50. Ogutu EO, Kang'ethe SK, Nyabola L, Nyong'o A. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia. East Afr Med J 1998; 75: 85-89
51. Rouvroy D, Bogaerts J, Nsengiumwa O, Omar M, Versailles L, Haot J. Campylobacter pylori, gastritis, and peptic ulcer disease in central Africa. Br Med J (Clin Res Ed) 1987; 295: 1174
52. Ciociola AA, McSorley DJ, Turner K, Sykes D, Palmer JB. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am J Gastroenterol 1999; 94: 1834-1840
53. Henry A, Batey RG. Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Aust N Z J Med 1998; 28: 345
54. Gisbert JR, Blanco M, Mateos JM, Fernandez-Salazar L, Fernandez-Bernejo M, Cantero J, Pajares JM. H pylori-negative duodenal ulcer prevalence and causes in 74 patients. Dig Dis Sci 1999; 11: 2295-2302
55. Nensey YM, Schubert TT, Bologna SD, Ma CK. Helicobacter pylori-negative duodenal ulcer. Am J Med 1991; 91: 15-18
56. Pilotto A, Franceschi M, Costa MC, Di Mario F, Valerio G. Helicobacter pylori test-and-eradication strategy. Lancet 2000; 356: 1683-1684
57. Arents NL, Thijs JC, van Zwet AA, Kleibeuker JH. Does the declining prevalence of Helicobacter pylori unmask patients with idiopathic peptic ulcer disease? Trends over an 8 year period. Eur J Gastroenterol Hepatol 2004; 16: 779-783
58. Kalaghchi B, Mekasha G, Jack MA, Smoot DT. Ideology of Helicobacter pylori prevalence in peptic ulcer disease in an inner-city minority population. J Clin Gastroenterol 2004; 38: 248-251
59. Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Garrigues V, Mora F, Castro M, Bujanda L, Cosme A, Castiella A, Gisbert JP, Hervas A, Lavas A. The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe. Helicobacter 2004; 9: 249-254
60. Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J Clin Gastroenterol 1998; 26: 60-63
61. Sprung DJ, Apter M, Allen B, Cook L, Allen B, Guarda L. The prevalence of Helicobacter pylori in duodenal ulcer disease. A community based study. Am J Gastroenterol 1996; 81: A169
62. Xia HH, Phung N, Kalantar JS, Talley NJ. Demographic and endoscopic characteristics of patients with Helicobacter pylori positive and negative peptic ulcer disease. Med J Aust 2000; 173: 515-519
63. Gislason GT, Emu B, Okolo III P, Pasncha PJ, Kalioo AN. Where have all the Helicobacter pylori gone? Etiologic factors in patients with duodenal ulcer presenting to a University Hospital. Gastrointest Endosc 1997; 45: 263
64. Raj SM, Yap K, Haq JA, Singh S, Hamid A. Further evidence for an exceptionally low prevalence of Helicobacter pylori infection among peptic ulcer patients in north-eastern peninsular Malaysia. Trans R Soc Trop Med Hyg 2001; 95: 24-27
65. Bytzer P, Aalykke C, Rune S, Weywadt L, Gjorup T, Eriksen J, Bonnevie O, Bekker C, Kromann-Andersen H, Kjaergaard J, Rask-Madsen J, Vilien M, Hansen J, Justesen T, Vyberg M, Teglbjaerg PS. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group. Scand J Gastroenterol 2000; 35: 1023-1032
66. Prach AT, Malek M, Tavakoli M, Hopwood D, Senior BW, Murray FE. H2-antagonist maintenance therapy versus Helicobacter pylori eradication in patients with chronic duodenal ulcer disease: a prospective study. Aliment Pharmacol Ther 1998; 12: 873-880
67. Martin IG, Diament RH, Dixon MF, Axon AT, Johnston D. Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur J Gastroenterol Hepatol 1995; 7: 207-209
68. Svoboda P, Krpensky A, Munzova H, Kunovska M. Helicobacter pylori after proximal selective vagotomy. Vnitr Lek 1991; 37: 772-375
69. Mitrokhina TV, Fitilev SB, Grafskaia ND, Pavlova MV. Role of Helicobacter pylori in the etiology of duodenal ulcer recurrence after selective proximal vagotomy. Khirurgiia (Mosk) 1996: 39-42
70. Kunzle JE, Modena JL, Ziliotto Junior A, Mendes JA. Helicobacter pylori after surgery for duodenal ulcer. Hepatogastroenterology 1997; 44: 599-603
71. Huang WH, Wang HH, Wu WW, Lai HC, Hsu CH, Cheng KS. Helicobacter pylori infection in patients with ulcer recurrence after partial gastrectomy. Hepatogastroenterology 2004; 51: 1551-1553
72. Archimandritis A, Apostolopoulos P, Sougioultzis S, Delladetsima I, Davaris P, Tzivras M. The CLO test is unreliable in diagnosing H. pylori infection in post-surgical stomach; is there any role of H. pylori in peptic ulcer recurrence? Eur J Gastroenterol Hepatol 2000; 12: 93-96
73. Lee YT, Sung JJ, Choi CL, Chan FK, Ng EK, Cheng JY, Leung WK, Chung SC. Ulcer recurrence after gastric surgery: is Helicobacter pylori the culprit? Am J Gastroenterol 1998; 93: 928-931
74. Leivonen M, Nordling S, Haglund C. The course of Helicobacter pylori infection after partial gastrectomy for peptic ulcer disease. Hepatogastroenterology 1998; 45: 587-591
75. Leivonen MK, Haglund CH, Nordling SF. Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol 1997; 9: 371-374
76. Ludtke FE, Maierhof S, Kohler H, Bauer FE, Tegeler R, Schauer A, Lepsien G. Helicobacter pylori colonization in surgical patients. Chirurg 1991; 62: 732-7338
77. Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A, Ohkusa T, Takagi A, Aoyama N, Haruma K, Okazaki K, Kusugami K, Suzuki M, Joh T, Azuma T, Yanaka A, Suzuki H, Hashimoto H, Kawai T, Sugiyama T. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 2004; 9: 9-16
78. Louw JA, Lucke W, Jaskiewicz K, Lastovica AJ, Winter TA, Marks IN. Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut 1995; 36: 544-547
79. Martino G, Paoletti M, Marcheggiano A, D'Ambra G, Delle Fave G, Annibale B. Duodenal ulcer relapse is not always associated with recurrence of Helicobacter pylori infection: a prospective 3 year follow-up study. Helicobacter 1999; 4: 213-217
80. Tepes B, Kavcic B, Gubina M, Krizman I. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication. Hepatogastroenterology 1999; 46: 1746-1750
81. Marshall BJ, Goodwin CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-1442
82. Laine L, Hopkins RJ, Girardi S. Has the impact of Helicobacter pylori therapy in ulcer recurrence in the United States been exaggerated? A meta-analysis of vigorously designed trials. Am J Gastroenterol 1998; 93: 1409-1415
83. Van der Hulst RW, Rauws EA, Koycu B, Keller JJ, Bruno MJ, Tijssen JG, Tytgat GN. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997; 113: 1082-1086
84. Bayerdorffer E, Miehlke S, Mannes GA, Sommer A, Hochiter W, Weingart J, Heldwein W, Klann H, Simon T, Schmitt W. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-1417
85. Fujioka T, Uribe RU, Kubota T, Murakami K, Kawasaki H, Nasu M. Peptic ulcer recurrence after Helicobacter pylori eradication: a 5-year follow-up study. Eur J Gastroenterol Hepatol 1995; 7 Suppl 1: S35-S38
86. Yang JC, Chen WH, Wang JJ, Lin JJ, Wang TH. Helicobacter pylori infection and recurrence of duodenal ulceration. A prospective long-term follow- up study. Gut 1998; 43 Suppl 2: A97
87. Huang JQ, Chen Y, Wilkinson J, Hunt RH. Does initial choice of Helicobacter pylori treatment regime influence the recurrence rate of duodenal ulcer? A meta-analysis. Gut 1996; 43 Suppl 3: A142
88. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, Taufer M, Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-312
89. Hildebrand P, Bardhan P, Rossi L, Parvin S, Rahman A, Arefin MS, Hasan M, Ahmad MM, Glatz-Krieger K, Terracciano L, Bauerfeind P, Beglinger C, Gyr N, Klan AK. Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 2002; 123: 653-654
90. O'Morain C, Dettmer A, Rambow A, von Fritsch E, Fraser AG. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer. Helicobacter 1996; 1: 130-137
91. Logan RP, Bardhan KD, Celestin LR, Theodossi A, Palmer KR, Reed PI, Baron JH, Misiewicz JJ. Eradication of Helicobacter pylori and prevention of recurrence of duodenal ulcer: a randomised, double-blind, multi-centre trial of omeprazole with and without clarithromycin. Aliment Pharmacol Ther 1995; 9: 417-423
92. Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-1235
93. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology 1996; 110: 1244-1252
94. Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers-a 12-month follow-up study. Lancet 1987; 2: 1109-1111
95. Penston JG. Review article: Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994; 8: 369-389
96. Ford A, Delaney B, Moy Maayedi P. A systematic review of Helicobacter pylori eradication therapy in duodenal and gastric ulcer healing and maintenance. Gut 2003; 52 Suppl 1: A17-A18
97. Xia HH, Wong BC, Wong KW, Wong SY, Wong WM, Lai KC, Hu WH, Chan CK, Lam SK. Clinical and endoscopic characteristics of non-Helicobacter pylori, non-NSAID duodenal ulcers: a long-term prospective study. Aliment Pharmacol Ther 2001; 15: 1875-1882
98. Higuchi K, Arakawa T, Fujiwara Y, Uchida T, Tominaga K, Watanabe T, Kuroki T. Is Helicobacter pylori-negative duodenal ulcer masked by a high prevalence of Helicobacter pylori in the general population? Am J Gastroenterol 1999; 94: 3083-3084
99. Aoyama N, Shinoda Y, Matsushima Y, Shirasaka D, Kimoshita Y, Kasuga M, Chiba T. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDs or stress? J Gastroenterol 2000; 35 Suppl 12: 63-67
100. Vu C, Ng YY. Prevalence of Helicobacter pylori in peptic ulcer disease in a Singapore hospital. Singapore Med J 2000; 41: 478-481
101. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24: 2-17
102. Kroupa R, Dite P, Milnzova H, Husova L. Incidence of gastroduodenal ulcer Helicobacter pylori positive and negative in the years 1996-2000 in region of Czech Republic. Gut 2002; 51 Suppl 2: A63
103. Gunay A. Absence of Helicobacter pylori infection in patients with duodenal peptic ulcer. Gut 2002; 51 Suppl 2: A63
104. Reinbach DH, Cruickshank G, McColl KEL. Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993; 34: 1344-1347
105. Kate V. Prevalence of Helicobacter pylori in normal controls and patients with upper alimentary disorders with special reference to complications of duodenal ulcer: a study in South India. PhD Thesis. 2000. Pondicherry University
106. Sakaguchi M, Oka H, Amemoto K, Honda M, Nakajima F, Kibi S, Lee K, Shimada M, Taniguchi K, Yamamoto N. Clinical investigation of perforated duodenal ulcer-with special reference to the presence of Helicobacter pylori infection and rate of recurrence. Nippon Shokakibyo Gakkai Zasshi 2002; 99: 1197-1204
107. Chowdhary SK, Bhasin DK, Panigrahi D, Malik AK, Kataria RN, Behra A, Roy P, Singh K. Helicobacter pylori infection in patients with perforated duodenal ulcer. Trop Gastroenterol 1998; 19: 19-21
108. Matsukura N, Onda M, Tokunaga A, Kato S, Yoshiyuki T, Hasegawa H, Yamashita K, Tomtitchong P, Hayashi A. Role of Helicobacter pylori infection in perforation of peptic ulcer: an age- and gender-matched case-control study. J Clin Gastroenterol 1997; 25 Suppl 1: S235-239
109. Sjostrom JE, Larsson H. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. J Med Microbiol 1996; 44: 425-433
110. Dykhuizen RS, Fraser A, McKenzie H, Golden M, Leifert C, Benjamin N. Helicobacter pylori is killed by nitrite under acidic conditions. Gut 1998; 42: 334-337
111. Presotto F, Sabini B, Cecchetto A, Plebani M, De Lazzari F, Pedini B, Betterle C. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter 2003; 8: 578-584
112. Djurkov VG, Grudeva-Popova JG, Houbavenska IN. A study of Helicobacter pylori infection in patients with pernicious anemia. Folia Med (Plovdiv) 2000; 42: 23-27
113. Gutierrez O, Sierra F, Gomez MC, Camargo F, Campylobacter pylori in chronic environmental gastritis and duodenal ulcer patients. Gastroenterology 1988; 94 Suppl 1: A163
114. Jain A, Buddhiraja S, Khurana B, Singhal R, Nair D, Arora P, Gangwal P, Mishra SK, Uppal B, Gondal R, Kar P. Risk factors for duodenal ulcer in north India. Trop Gastroenterol 1999; 20: 36-39
115. Chandrakumaran K, Vaira D, Hobsley M. Duodenal ulcer, Helicobacter pylori, and gastric secretion. Gut 1994; 35: 1033-1036
116. Tabel G, Hoa NT, Tarnawski A, Chen J, Domek M, Ma TY. Helicobacter pylori infection inhibits healing of the wounded duodenal epithelium in vitro. J Lab Clin Med 2003;142:421-430
117. el-Omar EM, Penman ID, Ardill JE, Chittajallu RS, Howie C, McColl KE. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease. Gastroenterology 1995; 109: 681-691